Decrease of the regulatory T-cell population by adoptive T-cell transfer in a mouse colorectal cancer transplant...

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Regulatory T cells (Tregs) play a crucial role in immune suppression within the tumor microenvironment.
• Adoptive T-cell transfer (ACT) is a promising cancer immunotherapy strategy.
• Understanding Treg dynamics during ACT is vital for optimizing treatment efficacy.

Purpose of the Study:

• To investigate the impact of ACT on Treg populations in a murine colorectal cancer model.
• To elucidate the in vitro mechanisms regulating Treg induction during ACT.
• To determine the role of Interferon-gamma (IFN-γ) in ACT-mediated Treg modulation.

Main Methods:

• In vivo analysis of Treg populations in peripheral blood, lymph nodes, and tumors of mice undergoing ACT.
• In vitro induction of Tregs from CD4+ cells using TGF-β, with or without LAK cells.
• Assessment of IFN-γ's role in Treg induction using exogenous IFN-γ and IFN-γ monoclonal antibodies (mAbs).

Main Results:

• ACT significantly suppressed Treg numbers in draining lymph nodes and tumors.
• Co-culture with LAK cells inhibited in vitro Treg induction.
• Exogenous IFN-γ suppressed Treg induction, while IFN-γ mAb addition increased Treg numbers.

Conclusions:

• ACT can lead to a decrease in Treg populations within tumor-bearing hosts.
• IFN-γ is implicated as a mechanism by which ACT inhibits Treg induction.
• These findings suggest potential strategies for modulating Treg responses in ACT for cancer therapy.